# Atomera Inc: overview ATOM · Nasdaq · CIK 1420520 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/atom.md) · [Financials](/companies/atom/financials.md) · [Filings](/companies/atom/filings.md) · [Insiders](/companies/atom/insiders.md) Latest reported revenue: [$158.0k](/filings/0001683168-26-006050.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001683168-26-006050). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [22.0](/filings/0001683168-25-007840.md) | [23.0 d](/filings/0001683168-26-001291.md) | [4.0](/filings/0001683168-26-003501.md) | [0.0](/filings/0001683168-26-006050.md) | [11.0](/filings/0001683168-25-007840.md) | [50.0 d](/filings/0001683168-26-001291.md) | [11.0](/filings/0001683168-26-003501.md) | [158](/filings/0001683168-26-006050.md) | | Gross margin | % | [86.4%](/filings/0001683168-25-007840.md) | [43.5% d](/filings/0001683168-26-001291.md) | [100.0%](/filings/0001683168-26-003501.md) | not reported | [(1063.6%)](/filings/0001683168-25-007840.md) | [(162.0%) d](/filings/0001683168-26-001291.md) | [(1045.5%)](/filings/0001683168-26-003501.md) | [83.5%](/filings/0001683168-26-006050.md) | | Operating margin | % | [(21818.2%)](/filings/0001683168-25-007840.md) | [(21182.6%) d](/filings/0001683168-26-001291.md) | [(136575.0%)](/filings/0001683168-26-003501.md) | not reported | [(52663.6%)](/filings/0001683168-25-007840.md) | [(9224.0%) d](/filings/0001683168-26-001291.md) | [(57490.9%)](/filings/0001683168-26-003501.md) | [(4277.8%)](/filings/0001683168-26-006050.md) | | Net margin | % | [(20886.4%)](/filings/0001683168-25-007840.md) | [(20247.8%) d](/filings/0001683168-26-001291.md) | [(130225.0%)](/filings/0001683168-26-006050.md) | not reported | [(50663.6%)](/filings/0001683168-25-007840.md) | [(8850.0%) d](/filings/0001683168-26-001291.md) | [(55209.1%)](/filings/0001683168-26-006050.md) | [(4010.1%)](/filings/0001683168-26-006050.md) | | Diluted EPS | $ per share | [(0.17)](/filings/0001683168-25-007840.md) | not reported | [(0.17)](/filings/0001683168-26-003501.md) | [(0.17)](/filings/0001683168-26-006050.md) | [(0.17)](/filings/0001683168-25-007840.md) | not reported | [(0.17)](/filings/0001683168-26-003501.md) | [(0.17)](/filings/0001683168-26-006050.md) | | Free cash flow | $k | [(2,895) d](/filings/0001683168-25-007840.md) | [(3,036) d](/filings/0001683168-26-001291.md) | [(4,786)](/filings/0001683168-26-003501.md) | [(3,515) d](/filings/0001683168-26-006050.md) | [(3,375) d](/filings/0001683168-25-007840.md) | [(3,244) d](/filings/0001683168-26-001291.md) | [(4,607)](/filings/0001683168-26-003501.md) | [(3,913) d](/filings/0001683168-26-006050.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.4](/filings/0001683168-23-000938.md) | [0.4](/filings/0001683168-24-001031.md) | [0.6](/filings/0001683168-25-001330.md) | [0.1](/filings/0001683168-26-001291.md) | [0.1](/filings/0001683168-26-001291.md) | | Gross margin | % | [100.0%](/filings/0001683168-23-000938.md) | [78.8%](/filings/0001683168-24-001031.md) | [94.9%](/filings/0001683168-25-001330.md) | [8.9%](/filings/0001683168-26-001291.md) | [(393.8%)](/filings/0001683168-26-001291.md) | | Operating margin | % | [(3882.3%)](/filings/0001683168-23-000938.md) | [(4588.0%)](/filings/0001683168-24-001031.md) | [(3759.5%)](/filings/0001683168-25-001330.md) | [(14323.0%)](/filings/0001683168-26-001291.md) | [(32496.9%)](/filings/0001683168-26-001291.md) | | Net margin | % | [(3928.5%)](/filings/0001683168-23-000938.md) | [(4565.7%)](/filings/0001683168-24-001031.md) | [(3598.2%)](/filings/0001683168-25-001330.md) | [(13655.6%)](/filings/0001683168-26-001291.md) | [(31036.9%)](/filings/0001683168-26-001291.md) | | Diluted EPS | $ per share | [(0.70)](/filings/0001683168-23-000938.md) | [(0.75)](/filings/0001683168-24-001031.md) | [(0.80)](/filings/0001683168-25-001330.md) | [(0.68)](/filings/0001683168-26-001291.md) | [(0.65)](/filings/0001683168-26-001291.md) | | Free cash flow | $m | [(12.6)](/filings/0001683168-23-000938.md) | [(12.5)](/filings/0001683168-24-001031.md) | [(14.6)](/filings/0001683168-25-001330.md) | [(13.3)](/filings/0001683168-26-001291.md) | [(14.9)](/filings/0001683168-26-001291.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/atom/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $26.0m | 2,990,446 | | Added +617,602 | | [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $16.5m | 1,890,019 | | Added +914,396 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $14.5m | 1,664,565 | | Added +376,404 | | [AVENIR CORP](/funds/1033475.md) | 2026-06-30 | $12.8m | 1,468,660 | | Added +7,245 | | [Baird Financial Group, Inc.](/funds/1648711.md) | 2026-06-30 | $11.7m | 1,340,888 | | Added +63,208 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $11.6m | 1,328,824 | | Added +1,152,963 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $8.6m | 990,370 | | Added +220,673 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $7.3m | 837,300 | Call | Added +462,000 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $7.1m | 809,991 | | Added +650,315 | | [Quantum Private Wealth, LLC](/funds/1929662.md) | 2026-06-30 | $6.5m | 743,895 | | Added +145,586 | ## Recent filings [All 521 filings](/companies/atom/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-06 | 16:06 ET | [10-Q](/filings/0001683168-26-006050.md) | Quarterly report, period 2026-06-30 | 0001683168-26-006050 | | 2026-08-04 | 16:45 ET | [8-K](/filings/0001683168-26-005944.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-26-005944 | | 2026-05-13 | 16:05 ET | [8-K](/filings/0001683168-26-003815.md) | 5.07 Shareholder vote results | 0001683168-26-003815 | | 2026-05-05 | 17:00 ET | [10-Q](/filings/0001683168-26-003501.md) | Quarterly report, period 2026-03-31 | 0001683168-26-003501 | | 2026-05-05 | 16:45 ET | [8-K](/filings/0001683168-26-003493.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-26-003493 | | 2026-03-27 | 16:02 ET | [DEF 14A](/filings/0001683168-26-002328.md) | Proxy statement, period 2026-05-12 | 0001683168-26-002328 | | 2026-02-24 | 17:09 ET | [10-K](/filings/0001683168-26-001291.md) | Annual report, period 2025-12-31 | 0001683168-26-001291 | | 2026-02-24 | 06:02 ET | [8-K](/filings/0001683168-26-001269.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-001269 | | 2026-02-23 | 06:05 ET | [8-K](/filings/0001683168-26-001242.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-001242 | | 2026-02-12 | 16:45 ET | [8-K](/filings/0001683168-26-000962.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-26-000962 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001683168-26-001291.md), filed Feb 24, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/ecf9c930-f6cd-4f59-b6f8-7984f836527e) ## About the filer - CIK: 1420520 - Tickers: ATOM - Exchange: Nasdaq - SIC code: 3674 Semiconductors & Related Devices - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:46 ET. No prices; not investment advice.